We believe that the stock price of Ionis Pharmaceuticals, a biotech company that specializes in discovering and developing RNA-targeted therapeutics, is undervalued at current levels of under $37. IONS stock is down 11% from the levels of around $42 it was at on March 23, 2020…
Ionis Pharmaceuticals Stock Looks Attractive At $37
2021-06-23T12:30:00-04:00June 23rd, 2021|
Related Posts
-
3 Companies to Watch as Nasdaq Warms Up to Cannabis Listings
May 14th, 2024